UBS Group AG institutional holdings, Q3 FY2022

Business Context and Reporting Period

This filing is a Form 13F-HR submitted by UBS Group AG for the quarter ended September 30, 2022. The report discloses equity holdings managed by UBS Group AG and ten other included institutional investment managers, including UBS Asset Management (Americas) Inc. and UBS O'Connor LLC. The filing was signed on November 1, 2022, by Rollins Lee Simmons.

Key Financial Metrics

As a Form 13F filing, this document reports portfolio holdings rather than the operating financial performance of UBS Group AG itself. Consequently, the filing does not contain data on revenue, profit, cash flow, margins, debt, or liquidity for the reporting entity.

  • Total Value of Reported Holdings: $228,092,856,000 (228,092,856 thousands)
  • Total Number of Holdings Entries: 19,366
  • Number of Included Managers: 10

Material Changes

The provided text contains only the cover page and summary statistics of the filing. It does not include the detailed schedule of securities or comparative data from the prior quarter. Therefore, specific material changes in holdings, additions, or deletions cannot be determined from this source text.

Guidance, Outlook, and Risks

This filing type does not include management commentary, forward-looking guidance, risk factors, or contingencies regarding the company's future performance. The document strictly serves as a regulatory disclosure of current equity positions.

Important Facts for Investors to Verify

  • Verify the total portfolio value of approximately $228.1 billion against the specific holdings schedule (not included in this text) to understand sector concentration.
  • Confirm the list of 10 included managers to ensure the reported assets represent the full scope of UBS's managed equity positions.
  • Note that this filing reflects positions as of September 30, 2022, and does not reflect subsequent market movements or trading activity.
  • Recognize that this document does not provide insight into UBS Group AG's own profitability or balance sheet health.